Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6Sanofi-Aventis Canada Inc.
01 32057913
02 32177772
01 6Irbesartan
01 6Tablet
01 32011-03-20
02 32016-05-30
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Brand Name : AVAPRO
Patent Number : 2057913
Filing Date : 1991-03-20
Strength per Unit : 75mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Brand Name : AVAPRO
Patent Number : 2057913
Filing Date : 1991-03-20
Strength per Unit : 150mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Brand Name : AVAPRO
Patent Number : 2057913
Filing Date : 1991-03-20
Strength per Unit : 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Brand Name : AVAPRO
Patent Number : 2177772
Filing Date : 1996-05-30
Strength per Unit : 75mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Brand Name : AVAPRO
Patent Number : 2177772
Filing Date : 1996-05-30
Strength per Unit : 150mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Brand Name : AVAPRO
Patent Number : 2177772
Filing Date : 1996-05-30
Strength per Unit : 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
LOOKING FOR A SUPPLIER?